Literature DB >> 15194317

Liver transplant recipients mortality on the waiting list: long-term comparison to Child-Pugh classification and MELD.

I F S F Boin1, M I Leonardi, A O Pinto, R S R Leme, E Udo, R S B Stucchi, E C Soares, L S Leonardi.   

Abstract

We sought to evaluate our experience concerning the high waiting list mortality rate for orthotopic liver transplantation (OLT) using the MELD (Model for End-Stage Liver Disease), which has been shown to predict short-term survival better than Child-Turcotte-Pugh (CTP) classification. The predominant end-stage disease was cirrhosis due to hepatitis C virus (67%), patient mean age was 36.8 years, and 72.1% were men. When the patients were included on a waiting list, the MELD score was stratified into W: 0 to 10; X: 11 to 20, and Y: 21 to 40 and the CPT as A: 5 to 6, B: 7 to 9, and C: 10 to 15. It was also observed that 77.8% of patients were on the waiting list, 16.4% underwent OLT and 5.8% had been removed. The estimated survival rate after 1 year was W = 85.4%; X = 83.3%, Y = 46.8%; A = 81.3%, B = 84.2%, C = 45.9%. Child median score was 8 +/- 1.5 (5 to 15) and the MELD was 14.7 +/- 5.1 (8 to 43). The mortality rate was 20.2%. Severe patients classified as Y or C showed greater mortality than the other groups (P <.001), but no significant difference between Y and C strata. The mortality rate was the same as in previous years.

Entities:  

Mesh:

Year:  2004        PMID: 15194317     DOI: 10.1016/j.transproceed.2004.03.095

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Survival tree and MELD to predict long term survival in liver transplantation waiting list.

Authors:  Emília Matos do Nascimento; Basilio de Bragança Pereira; Samanta Teixeira Basto; Joaquim Ribeiro Filho
Journal:  J Med Syst       Date:  2010-03-03       Impact factor: 4.460

2.  Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.

Authors:  David E Kaplan; Feng Dai; Ayse Aytaman; Michelle Baytarian; Rena Fox; Kristel Hunt; Astrid Knott; Marcos Pedrosa; Christine Pocha; Rajni Mehta; Mona Duggal; Melissa Skanderson; Adriana Valderrama; Tamar H Taddei
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

3.  [Liver transplantation: deciding between need and donor allocation].

Authors:  C P Strassburg; T Becker; J Klempnauer; M P Manns
Journal:  Internist (Berl)       Date:  2004-11       Impact factor: 0.743

4.  Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation.

Authors:  Masatoshi Ishigami; Takashi Honda; Akihiko Okumura; Tetsuya Ishikawa; Makoto Kobayashi; Yoshiaki Katano; Yasuhiro Fujimoto; Tetsuya Kiuchi; Hidemi Goto
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

5.  Comparison of the Child-Turcotte-Pugh classification and the model for end-stage liver disease score as predictors of the severity of the systemic inflammatory response in patients undergoing living-donor liver transplantation.

Authors:  Sang-Hyun Hong; Jeong-Eun Kim; Mi-La Cho; Yu-Jung Heo; Jong-Ho Choi; Jung-Hyun Choi; Jaemin Lee
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

6.  Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis.

Authors:  David E Kaplan; Feng Dai; Melissa Skanderson; Ayse Aytaman; Michelle Baytarian; Kathryn D'Addeo; Rena Fox; Kristel Hunt; Astrid Knott; Rajni Mehta; Marcos Pedrosa; Christine Pocha; Adriana Valderrama; Tamar Taddei
Journal:  Dig Dis Sci       Date:  2016-07-12       Impact factor: 3.199

7.  Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases.

Authors:  Wenkuan Li; Jawaher Abdullah Alamoudi; Nagsen Gautam; Devendra Kumar; Macro Olivera; Yeongjin Gwon; Sandeep Mukgerjee; Yazen Alnouti
Journal:  Int J Hepatol       Date:  2022-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.